Oculis Holding AG OCS 深 沪
已收盘 05-29 16:00:00 美东时间
22.705
-6.945
-23.42%
华盛通- 最 高29.645
- 今 开29.30
- 成交量 284.53万股
- 最 低 20.01
- 昨 收 29.65
- 总市值 13.71亿
- 52周最高 34.475
- 市盈率 静 --
- 换手率 4.71%
- 52周最低 16.00
- 委 比 -52.27%
- 总股本 6038.81万
- 历史最高 34.475
- 量 比 6.10
- 振 幅 32.50%
- 历史最低 6.26
- 每 手 1
- 风险率 4.45%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多重磅管线III期失败，上市无望...赛道“黑马”迎暴击
（来源：一度医药） 2026年5月29日，瑞士生物制药公司Oculis Holding（NASDAQ:OCS）公告称，公司核心管线OCS-01滴眼液治疗糖尿病...
05-30 11:11
美股周涨跌榜 | Digital Turbine涨93.0%；Unusual Machines涨89.4%；Braiin Limited涨78.4%
Digital Turbine涨93.0%；Unusual Machines涨89.4%；Braiin Limited涨78.4%
05-30 06:27
Oculis Holding Reports Topline Results From Phase 3 DIAMOND-1 And DIAMOND-2 Trials Of OCS-01 Eye Drops In Patients With DME; Primary BCVA Endpoint Not Met
The primary endpoint of mean change in best corrected visual acuity (BCVA) from baseline to week 52 in both Phase 3 trials was not met The secondary endpoint of retinal thickness showed a substantial and
05-30 03:12
美股大行评级 | 英伟达绩后获11家大行集体上调目标价；劳氏、ELF、Intuit、VF等惨遭多家大行下调目标价
今日重点评级关注：康托·菲茨杰拉德：维持Ultragenyx药业"超配"评级，目标价从84美元升至96美元；Ascendiant Capital：维持Liqtech国际"买入"评级，目标价从4.3美元升至4.4美元
05-22 10:18
Guggenheim Initiates Coverage On Oculis Holding with Buy Rating, Announces Price Target of $75
Guggenheim analyst Yatin Suneja initiates coverage on Oculis Holding (NASDAQ:OCS) with a Buy rating and announces Price Target of $75.
05-21 22:35
美股大行评级 | 花旗上调英特尔目标价至130美元；大摩上调英伟达目标价至285美元；National 、Yesway获多家大行首予买入评级
今日重点评级关注：TD Cowen：维持Strive"买入"评级，目标价从28美元升至30美元；蒙特利尔银行：维持KinderCare Learning"跑赢大市"评级，目标价从4美元升至6美元
05-19 10:55
美股大行评级 | 富国银行上调英伟达目标价从265美元升至315美元；Alamar、AEVEX获多家大行首予“买入”评级
今日重点评级关注：Needham：维持Artiva Biotherapeutics"买入"评级，目标价从18美元升至41美元；HC Wainwright & Co.：维持SAB Biotherapeutics"买入"评级，目标价从7美元升至10美元
05-13 11:46
HC Wainwright & Co. Maintains Buy on Oculis Holding, Raises Price Target to $47
HC Wainwright & Co. analyst Yi Chen maintains Oculis Holding (NASDAQ:OCS) with a Buy and raises the price target from $44 to $47.
05-13 00:48
Oculis to Present at Upcoming Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting
Oculis Holding AG will present updates on its late-stage pipeline and key unmet medical needs in ophthalmology at the ARVO 2026 Annual Meeting. Highlights include findings from the DME AWARE Delphi Study emphasizing the need for non-invasive therapies for diabetic macular edema (DME), post-hoc analysis of Privosegtor's impact on retinal ganglion cell loss in optic neuritis, and a corporate update on upcoming milestones. The company is advancing O...
05-01 08:00
美股大行评级 | 大摩上调Lumentum目标价从595美元升至710美元；康宁、道富银行、Ally Financial获多家机构上调目标价
今日重点评级关注：Canaccord Genuity：维持Vertical Aerospace"买入"评级，目标价从9.5美元升至10.5美元；Canaccord Genuity：维持AtaiBeckley Inc."买入"评级，目标价从14美元升至15美元
04-21 11:25
